You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 292 No. 19, November 17, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •HIV/AIDS
 •Sexually Transmitted Diseases
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

HAART and Sexual Risk Behavior

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Crepaz and colleagues conclude that human immunodeficiency virus (HIV)–infected patients taking highly active antiretroviral therapy (HAART) did not exhibit increased sexual risk behavior, even when therapy achieved an undetectable viral load.1 In their discussion, the authors state that medical factors, such as duration of HAART or disease stage, might elucidate their findings because patients initiating HAART may have symptomatic illness that decreases their interest in sex.

In a recent study, my colleagues and I examined the relationship between unprotected sex (defined as anal or vaginal sex without a condom within the past 3 months) and antiretroviral use in a cross-sectional survey conducted in 874 randomly selected, sexually active patients at 6 public HIV clinics in California in 1998-1999.2 We found a decreased odds ratio (OR) for unprotected sex with both antiretroviral use (OR, 0.5; 95% confidence interval [CI], 0.4-0.7) and self-reported undetectable HIV RNA level (OR, . . . [Full Text of this Article]

Catherine Diamond, MD, MPH
diamondc@uci.edu
Department of Medicine
Divisions of Infectious Diseases and Epidemiology
University of California
Irvine



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

HAART and Sexual Risk Behavior
Carla Makhlouf Obermeyer and Rahul Rajkumar
JAMA. 2004;292(19):2335.
EXTRACT | FULL TEXT  

HAART and Sexual Risk Behavior—Reply
Nicole Crepaz, Gary Marks, and Trevor A. Hart
JAMA. 2004;292(19):2336.
EXTRACT | FULL TEXT  

Highly Active Antiretroviral Therapy and Sexual Risk Behavior: A Meta-analytic Review
Nicole Crepaz, Trevor A. Hart, and Gary Marks
JAMA. 2004;292(2):224-236.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.